Search results
Results from the WOW.Com Content Network
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. [3] The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Fresenius Medical Care, a publicly traded company of which Fresenius owns 30.8%, focuses on patients with chronic kidney failure. [4] With its North American headquarters in Waltham, Massachusetts , it holds a 38% market share in the dialysis market in the United States.
NxStage Medical, Inc. (/ ˈ n ɛ k ˌ s t eɪ dʒ / NEK-stayj [2]) is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product. [1]
Fresenius, for example, reported $1.3 billion in profits in 2021 and gave its chief executive officer nearly $6 million in compensation, SEIU-UHW leaders have pointed out.
For premium support please call: 800-290-4726 more ways to reach us
Vifor Fresenius Medical Care Renal Pharma (VFMCRP), the joint company with Fresenius Medical Care since 2010, gives CSL Vifor access to a network of dialysis centers. [23] It is active in the treatment of chronic kidney disease (CKD), [31] chronic kidney disease-associated pruritus, [32] renal anemia [33] and hyperphosphatemia. [23]
For premium support please call: 800-290-4726 more ways to reach us
Starting with 5 employees, DSI was able to create a modular design for hospital buildings, reducing the cost and time to create the building while improving the quality of the facility. In April 2006, financed by Centre Partners, DSI purchased 105 dialysis clinics and four other programs from Fresenius Medical Care Holdings, Inc.